feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Invisible Battle: Woman's Fight Against Rare Disease

Invisible Battle: Woman's Fight Against Rare Disease

28 Dec, 2025

•

Summary

  • Friedreich's ataxia causes loss of muscle control and coordination.
  • The disease affects about 5,000 people in the U.S.
  • A new drug offers hope but is not a cure for FA.
Invisible Battle: Woman's Fight Against Rare Disease

Tiffany Fransen, now 27, lives with Friedreich's ataxia (FA), a rare neurodegenerative disease that impairs muscle control and coordination. Diagnosed five years ago, Tiffany experiences symptoms like staggering and slurred speech, often leading to confusion and unwanted questions, such as assumptions about intoxication.

FA results from a genetic mutation affecting energy production in nerve and muscle cells, leading to progressive weakness and coordination issues. The condition affects approximately 5,000 individuals in the U.S., with symptoms typically appearing in childhood, though later onset is also common. Tiffany's journey to diagnosis took six years, highlighting the rarity and limited awareness of FA among medical professionals.

Life with FA necessitates significant adjustments for Tiffany and her family, including her husband Alex, who adapted his career to support her. While a recently approved medication, Skyclarys, can slow disease progression, it is not a cure. Tiffany remains determined to live a full life, emphasizing her capabilities and fulfillment despite the challenges.

trending

Baggage handler trapped on plane

trending

Pittman accused in synagogue fire

trending

Red Wings beat Hurricanes

trending

Anthropic releases Claude Cowork feature

trending

Texans rolling into playoffs

trending

FA Cup fourth-round draw

trending

Tottenham close to Gallagher deal

trending

Koepka returns to PGA Tour

trending

Celtics Pacers game on Peacock

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Friedreich's ataxia is a rare, inherited neurodegenerative disease that causes loss of coordination and muscle control.
Approximately 5,000 people in the U.S. are affected by Friedreich's ataxia.
Currently, there is no cure for Friedreich's ataxia, but a treatment exists to slow its progression.

Read more news on

Healthside-arrow

You may also like

Michelle Williams' Powerful Golden Globe Win Amidst Stage Role

1 day ago • 4 reads

article image

TV Star's Agonizing 'Suicide Disease' Battle

14 Dec, 2025 • 147 reads

article image

Hawke's Sardi's Portrait: A Career Milestone

7 Dec, 2025 • 154 reads

article image

Blind Bartender Fights to Clear Name in Kidnapping Mystery

13 Nov, 2025 • 168 reads

article image

Pioneering Marine Biologist Illuminates the Ocean's Depths

12 Nov, 2025 • 140 reads

article image